These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19188673)

  • 1. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.
    Roukos DH
    J Clin Oncol; 2009 Mar; 27(8):1337-8; author reply 1338-9. PubMed ID: 19188673
    [No Abstract]   [Full Text] [Related]  

  • 2. International randomized trials' attention to locoregional breast cancer control and promise of personal genomics and whole-genome scans for personalized approaches.
    Zografos G; Roukos DH
    Ann Surg Oncol; 2009 Jan; 16(1):222-3. PubMed ID: 18989725
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine.
    Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):772-3. PubMed ID: 18726130
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and challenges toward personalized breast cancer local control.
    Roukos DH; Lykoudis E; Liakakos T
    J Clin Oncol; 2008 Sep; 26(26):4360-1; author reply 4361-2. PubMed ID: 18779627
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.
    Ziogas D; Roukos DH
    Ann Surg Oncol; 2009 Jul; 16(7):1771-82. PubMed ID: 19322611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes in breast cancer evaluation and management: divide and conquer.
    Peppercorn J; Perou CM; Carey LA
    Cancer Invest; 2008 Feb; 26(1):1-10. PubMed ID: 18181038
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene expression and cancer: getting it together.
    Nat Genet; 2002 May; 31(1):1-2. PubMed ID: 11984554
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of breast cancer in the genome era.
    Morrow PK; Hortobagyi GN
    Annu Rev Med; 2009; 60():153-65. PubMed ID: 19630569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic approaches in cancer biology.
    Matros E; Wang ZC; Richardson AL; Iglehart JD
    Surgery; 2004 Sep; 136(3):511-8. PubMed ID: 15349094
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression profiling: decoding breast cancer.
    de Snoo F; Bender R; Glas A; Rutgers E
    Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
    Heaton AH
    Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors.
    Landmark-Høyvik H; Reinertsen KV; Loge JH; Fosså SD; Børresen-Dale AL; Dumeaux V
    Pharmacogenomics J; 2009 Oct; 9(5):333-40. PubMed ID: 19546881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome analysis personalizes breast cancer treatment.
    Cancer Discov; 2012 Dec; 2(12):OF6. PubMed ID: 23230207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic profiling of breast cancer.
    Pandey A; Singh AK; Maurya SK; Rai R; Tewari M; Kumar M; Shukla HS
    J Surg Oncol; 2009 May; 99(6):386-92. PubMed ID: 19235775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling and personalized predictive pathology: challenge to the academic surgical pathology community.
    Giordano TJ
    Am J Surg Pathol; 2006 Mar; 30(3):402-4. PubMed ID: 16538062
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.